Enerpac Tool Group (NYSE: EPAC) posts 10-quarter-high product growth as EMEA service slump and $51m buyback reshape its fiscal 2026 outlook
How Cambium Networks Corporation’s Nasdaq delisting reshapes investor risk, liquidity, and valuation outlook (NASDAQ: CMBM)
Can SoundHound AI, Inc.’s agentic AI strategy reshape enterprise workflow automation markets? (NASDAQ: SOUN)
Read More 4 minute read Pharma Industry News Novo Nordisk eyes FDA approval for high-dose 7.2mg Wegovy after STEP UP trial shows 21% weight loss Novo Nordisk seeks U.S. approval for 7.2mg Wegovy after 21% average weight loss in trials. Can it outpace Eli Lilly’s Zepbound in the obesity drug race? byPallavi MadhirajuSeptember 16, 2025